“ICHOR Vascular Inc. has developed a Percutaneous Reperfusion System to treat Acute Limb Ischemia (ALI) and other embolic/thrombotic events….
It’s called Panacea!


"The device exceeded my expectations in terms of bulk retrieval of organized thrombus, the ease of maneuvering the entire low profile system using rapid exchange technique, and the durability of the device in treating large clot burden.”
Vascular Interventional Radiologist Tampa, FL

“Panacea is a much needed technology for treating peripheral arterial disease (PAD) in the lower limbs. Current technologies do not deliver the desired therapeutic results and I believe the Panacea technology can deliver conclusive therapy with a design that is both elegant and intuitive. Lack of reasonable therapies will make Panacea a go-to device”

- Dr. J A Mustapha, FACC, FSCAI, Entrepreneur

WHY PANACEA?

PATIENT

  • A percutaneous approach (less invasive)
  • Minimal-no drug required (fewer complications)
  • No general anesthesia required
  • A safe and effective same day treatment option
  • Addresses the non-surgical candidates

HOSPITALS

  • Low cost treatment option with no capital outlay
  • Avoidance-reduction of costly drug therapies
  • Reduces hospital stays and ICU time
  • Health economics as a 1st line therapy

INVESTOR

  • An elegant yet disruptive solution
  • 1-2 year expected returns
  • Well vetted “get to market” strategy
  • Low risk development model
  • Solid product lines for Strategics (>80% margin)

PHYSICIANS 

  • Minimally invasive technology
  • Specifically designed for lower limb reperfusion
  • One size fits all system
  • Incorporates what works in surgery
  • Efficient, easy to adopt into your practice